Belpointe Asset Management LLC Becton Dickinson & CO Transaction History

Belpointe Asset Management LLC

$1.69 Billion
Q1 2025

A detailed history of Belpointe Asset Management LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Belpointe Asset Management LLC holds 1,094 shares of BDX stock, worth $188,813. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,094

Previous 2,319 52.82%

Holding current value

$188,813

Previous $526,000 52.47%

% of portfolio

0.01%

Previous 0.03%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 20, 2025	SELL	$222.79 - $249.08 $272,917 - $305,123	-1,225 Reduced 52.82%	1,094 $250,000
Q4 2024 Feb 13, 2025	SELL	$220.02 - $243.75 $2,200 - $2,437	-10 Reduced 0.43%	2,319 $526,000
Q3 2024 Nov 12, 2024	BUY	$221.47 - $242.41 $51,381 - $56,239	232 Added 11.06%	2,329 $561,000
Q2 2024 Aug 02, 2024	BUY	$225.07 - $246.17 $49,290 - $53,911	219 Added 11.66%	2,097 $490,000
Q1 2024 May 08, 2024	SELL	$233.45 - $247.73 $4,902 - $5,202	-21 Reduced 1.11%	1,878 $464,000
Q4 2023 Feb 13, 2024	SELL	$232.24 - $267.23 $20,901 - $24,050	-90 Reduced 4.52%	1,899 $463,000
Q3 2023 Nov 15, 2023	BUY	$254.9 - $283.59 $150,136 - $167,034	589 Added 42.07%	1,989 $514,000
Q2 2023 Aug 14, 2023	SELL	$238.39 - $265.32 $234,575 - $261,074	-984 Reduced 41.28%	1,400 $369,000
Q1 2023 May 15, 2023	BUY	$229.71 - $259.35 $19,984 - $22,563	87 Added 3.79%	2,384 $590,000
Q4 2022 Feb 08, 2023	SELL	$218.29 - $256.91 $82,513 - $97,111	-378 Reduced 14.13%	2,297 $584,000
Q3 2022 Nov 14, 2022	BUY	$51.03 - $264.23 $46,131 - $238,863	904 Added 51.04%	2,675 $596,000
Q2 2022 Aug 02, 2022	BUY	$234.74 - $275.42 $2,112 - $2,478	9 Added 0.51%	1,771 $437,000
Q1 2022 Apr 28, 2022	SELL	$243.64 - $270.48 $151,056 - $167,697	-620 Reduced 26.03%	1,762 $469,000
Q4 2021 Feb 15, 2022	BUY	$230.08 - $250.94 $217,425 - $237,138	945 Added 65.76%	2,382 $599,000
Q3 2021 Nov 15, 2021	SELL	$232.72 - $256.47 $105,654 - $116,437	-454 Reduced 24.01%	1,437 $354,000
Q2 2021 Aug 09, 2021	BUY	$232.65 - $254.58 $185,654 - $203,154	798 Added 73.01%	1,891 $460,000
Q1 2021 May 14, 2021	SELL	$232.09 - $256.88 $19,727 - $21,834	-85 Reduced 7.22%	1,093 $266,000
Q4 2020 Feb 16, 2021	BUY	$221.92 - $245.94 $221 - $245	1 Added 0.08%	1,178 $295,000
Q3 2020 Nov 13, 2020	BUY	$215.77 - $276.76 $14,025 - $17,989	65 Added 5.85%	1,177 $274,000
Q3 2020 Nov 13, 2020	SELL	$215.77 - $276.76 $3,883 - $4,981	-18 Reduced 1.59%	1,112 $256,000
Q2 2020 Jul 20, 2020	BUY	$219.9 - $263.41 $3,958 - $4,741	18 Added 1.62%	1,130 $271,000
Q1 2020 Jul 20, 2020	SELL	$195.69 - $279.01 $26,026 - $37,108	-133 Reduced 10.68%	1,112 $256,000
Q4 2019 Feb 18, 2020	BUY	$236.45 - $266.82 $108,767 - $122,737	460 Added 58.6%	1,245 $339,000
Q3 2019 Jan 16, 2020	SELL	$230.58 - $256.08 $922 - $1,024	-4 Reduced 0.51%	785 $199,000
Q2 2019 Nov 22, 2019	SELL	$217.4 - $246.08 $80,438 - $91,049	-370 Reduced 31.92%	789 $0
Q1 2019 Jun 11, 2019	BUY	$206.05 - $248.17 $92,928 - $111,924	451 Added 63.7%	1,159 $290,000
Q4 2018 Mar 06, 2019	SELL	$204.73 - $257.93 $76,773 - $96,723	-375 Reduced 34.63%	708 $160,000
Q3 2018 Nov 23, 2018	SELL	$233.07 - $256.0 $346,108 - $380,160	-1,485 Reduced 57.83%	1,083 $283,000
Q2 2018 Aug 06, 2018	BUY	$208.1 - $233.85 $534,400 - $600,526	2,568 New	2,568 $615,000
Q1 2018 Aug 06, 2018	SELL	$205.46 - $240.27 $237,717 - $277,992	-1,157 Closed	0 $0
Q4 2017 Feb 15, 2018	SELL	$189.0 - $222.64 $8,883 - $10,464	-47 Reduced 3.9%	1,157 $248,000
Q3 2017 Nov 16, 2017	BUY	$186.89 - $198.9 $225,015 - $239,475	1,204	1,204 $236,000

Others Institutions Holding BDX

# of Institutions

1,806

Shares Held

257M

Call Options Held

3.24M

Put Options Held

841K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $49.2B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belpointe Asset Management LLC with notifications on news.

Account

Belpointe Asset Management LLC Becton Dickinson & CO Transaction History